RN high efficiency leucocyte removal filter for red cells – neonatal, with unique needleless access port. Clinically proven media technology significantly reduces the risk of leucocyte associated transfusion complications such as microaggregates, alloimmunisation, febrile reactions, refractoriness to platelets, Cytomegalovirus and immunosuppression.

• Easy prime technology
• Enhanced ease of use
• Unique needleless access port
• High efficiency leucocyte removal
• High red cell recovery
• Minimal filter hold-up volume(12ml)

RC high efficiency leucocyte removal filter for either one or two units of red cells, supplied with or without self-leveling administration set. Clinically proven media technology significantly reduces the risk of leucocyte associated transfusion complications such as microaggregates, alloimmunisation, febrile reactions, refractoriness to platelets, Cytomegalovirus and immunosuppression.

• For standard or rapid flow applications
• Easy prime technology
• Enhanced ease of use
• High efficiency leucocyte removal
• High red cell recovery
• Minimal filter hold-up volume
• Rapid priming without saline
• Bedside filtration of either one or two units of red cells

PL1BE high efficiency leucocyte removal filter for platelet transfusion - neonatal, with unique needleless syringe adaptor. Clinically proven media technology significantly reduces the risk of leucocyte associated transfusion complications such as microaggregates, alloimmunisation, febrile reactions, refractoriness to platelets, Cytomegalovirus and immunosuppression.

• High efficiency leucocyte removal
• Removal of complement
• Platelet recovery greater than 90%
• Easy prime technology
• Minimal filter hold-up volume (2ml)
• Unique needleless syringe adaptor
• Gravity prime

PL2VAE or 3 VAE high efficiency leucocyte removal filter for use of up to 400ml of random pooled platelets. Clinically proven media technology significantly reduces the risk of leucocyte associated transfusion complications such as microaggregates, alloimmunisation, febrile reactions, refractoriness to platelets, Cytomegalovirus and immunosuppression.

• Easy prime technology
• Enhanced ease of use

LPS high efficiency leucocyte removal filter for use with up to 1600ml fresh frozen plasma, with or without administration set. Clinically proven media technology significantly reduces the risk of leucocyte associated transfusion complications such as microaggregates, alloimmunisation, febrile reactions, refractoriness to platelets, Cytomegalovirus and immunosuppression.

• Indicated for use with up to 1600ml fresh frozen plasma.
• Minimal filter hold-up volume
• Easy to use

SQ40 40um blood transfusion filter. 40-micron screen filter for rapid transfusion of allogeneic or salvaged blood products. Removes clots, microaggregates and particulate debris from stored blood products. High filtering capacity designed for the administration of multiple blood products. Haemonetics 40-micron polyester screen is process controlled and monitored to ensure uniformity of pore size. This assures maximum patient protection from microaggregates, clots and particulate debris from stored or salvaged blood.